|
Hugel is a biopharmaceutical company that researches, develops, manufactures, and sells medical aesthetic products. Its core business involves botulinum toxin type A, marketed under the brand Botulax (Letybo), and hyaluronic acid (HA) dermal fillers, sold as The Chaeum (Persnica). The company also offers skin boosters under the brand Byrezen, absorbable sutures for facial lifting under the Blue Rose brand, and dermocosmetics under the Wellage and Byrezen BR brands. Hugel serves healthcare professionals and consumers in the United States, Europe, China, and markets in Southeast Asia, Oceania, and Latin America. The company operates through internal sales and marketing divisions and subsidiaries, including Hugel America, Inc., Hugel Australia PTY LTD, and HUGEL Shanghai Aesthetics. A key subsidiary, Acros, focuses on the R&D and manufacturing of HA fillers, while Jayworld, acquired in 2020, handles the production of absorbable sutures. Hugel was founded in 2001 and has established partnerships with local distributors and pharmaceutical companies in various regions to facilitate market entry and distribution. Summarised from the company's own disclosures, fiscal year ended Mar 2026 |
Industry Biotechnology | Homepage hugel-inc.com |
| Sector Healthcare | IR page hugel-inc.com | |
|
Tags
botulinum toxin, hyaluronic acid fillers, skin boosters, absorbable sutures, dermocosmetics, medical aesthetics, aesthetic injectables, facial lifting, anti-aging, Botulax, Letybo, The Chaeum, Persnica, Byrezen, Blue Rose, Wellage, Byrezen BR, Hugel America Inc., Hugel Australia PTY LTD, HUGEL Shanghai Aesthetics, Acros, Jayworld, Hugel Pharma
|
Press page hugel-inc.com/kr/media/news |
Metrics
| Valuation | |
|---|---|
| Market cap | $ 3.002T |
| Market cap (USD) | $ 2.21B |
| P/E | 16.63 |
| PEG | 0.48 |
| P/BV | 2.85 |
| P/S | 6.26 |
| P/OCF | 16.55 |
| P/FCF | 20.24 |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 16.1% |
| ROI | 14.8% |
| ROIC | 15.8% |
| Profit margin | 33.1% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | Yes |
| Revenue up 3y | Yes |
| Revenue up 5y | Yes |
| Earnings growth 3y (net profit CAGR) | 34.9% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | Yes |
| Buying back stock | — |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | — |
| Quality score | 50.0% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 425.11B | 373.047B | 319.7B | 281.675B | 231.859B | 211.038B | 204.568B | 182.392B | 182.085B | 124.189B | 65.066B | 40.35B | 29.17B |
| Net profit | 140.872B | 135.814B | 93.076B | 57.332B | 57.73B | 41.992B | 44.612B | 69.736B | 72.827B | 50.901B | 33.929B | 13.15B | 7.307B |
| Free cash flow | 136.664B | 136.697B | 93.988B | 47.803B | 62.061B | 57.325B | 64.711B | 56.694B | 57.848B | 29.519B | 7.395B | 4.694B | -10.386B |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (KRW) | 31.2B | 62.8B | 55.4B | 37.5B | 28B | 28.4B | 53.2B | 44.1B | 48.4B | 75B |
| ↳ YoY growth | +51.8% | +101.0% | -11.8% | -32.4% | -25.3% | +1.6% | +87.0% | -17.0% | +9.6% | +55.0% |
| ↳ 5y CAGR | +36.8% | +14.3% | +6.4% | -1.9% | -3.3% | -4.4% | +5.3% | +21.8% | ||
| Borrowings, current (KRW) | 300M | — | — | 200M | — | — | 97.8B | 0.00 | 0.00 | 25.7B |
| Borrowings, non-current (KRW) | — | 79.6B | 82.9B | 86.4B | 90.1B | — | — | 88.8B | — | — |
| Bonds payable (KRW) | — | 79.6B | 82.9B | 86.4B | 90.1B | — | 97.8B | 88.8B | 0.00 | 25.7B |
| Cash and deposits (KRW) | 64.9B | 31.3B | 29B | 15.3B | 62.4B | 294B | 132B | 106B | 130B | 210B |
| Intangible assets (KRW) | 63.9B | 63.7B | 112B | 134B | 170B | 197B | 200B | 182B | 196B | 191B |
| Net debt (borrowings + leases - cash) (KRW) | -64.6B | 48.3B | 53.9B | 71.3B | 27.7B | — | -34B | -17.2B | -130B | -184B |
| Cash flow detail | ||||||||||
| Operating cash flow (KRW) | 45.1B | 64.2B | 65.8B | 77B | 74.3B | 85.9B | 80.6B | 118B | 149B | 150B |
| Purchases of property, plant and equipment (KRW) | -15.6B | -6.34B | -9.1B | -12.3B | -17B | -23.9B | -32.8B | -23.7B | -12.4B | -13.4B |
| Purchases of intangible assets (KRW) | -469M | -884M | -7.62B | -16.1B | -28.2B | -24.5B | -12.2B | -16.8B | -21B | -16.1B |
| Dividends paid (cash effect) (KRW) | — | — | — | — | — | — | 0.00 | -106M | 0.00 | 0.00 |
| Share buybacks (cash effect) (KRW) | -5.97B | -2.09M | -41.3B | -46.2B | — | -36B | -44.5B | -122B | -172B | -1.32B |
| Interest paid (cash effect) (KRW) | — | — | — | -1.79B | -116M | -87M | -99.4M | -55.1M | -547M | -518M |
| Income taxes paid (cash effect) (KRW) | -3.5B | -17.2B | -16B | -14.2B | -27.9B | -26.9B | -20.5B | -37.2B | -39B | -47.8B |
| Free cash flow (OCF - PPE - intangibles) (KRW) | 29B | 57B | 49.1B | 48.6B | 29.1B | 37.5B | 35.6B | 77.2B | 116B | 121B |
| Income detail | ||||||||||
| Total comprehensive income (KRW) | 50.9B | 81.2B | 72.8B | 47B | 48.9B | 69.8B | 63.4B | 97.9B | 161B | 150B |
| Comprehensive income to owners (KRW) | 43.3B | 72.7B | 67.7B | 40.1B | 47.3B | 64.8B | 58.1B | 92.3B | 153B | 144B |
| Reported | Jul 2, 2018 | Jul 2, 2018 | Apr 1, 2019 | Mar 30, 2020 | Mar 18, 2021 | Mar 21, 2024 | Mar 21, 2025 | Mar 21, 2025 | Mar 21, 2025 | Mar 20, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpDisclosures filed with DART (material events and exchange disclosures), newest first, headlines as filed in Korean. The link opens the filing on DART. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Hugel
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| MEMS | 3.14% | 4,164 | $ 709.544K | Jun 30, 2026 |
| MEMX | 0.68% | 1,994 | $ 339.777K | Jun 30, 2026 |
| AVEE | 0.08% | 729 | $ 103.968K | Nov 16, 2026 |
| DFSE | 0.01% | 560 | $ 82.667K | Nov 12, 2026 |
| DFEM | 0.01% | 7,281 | $ 1.075M | Nov 12, 2026 |
| DEXC | 0.01% | 184 | $ 27.162K | Nov 12, 2026 |
| AVEM | 0.01% | 12,247 | $ 1.747M | Nov 16, 2026 |
| AVXC | 0.01% | 186 | $ 26.527K | Nov 16, 2026 |
| DFAE | 0.01% | 3,733 | $ 551.063K | Nov 12, 2026 |
| DFAX | 0.00% | 3,720 | $ 549.144K | Nov 12, 2026 |
| AVSE | 0.00% | 52 | $ 7,416.08 | Nov 16, 2026 |